<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01422629</url>
  </required_header>
  <id_info>
    <org_study_id>HIFU/F/FA/Dec2010</org_study_id>
    <nct_id>NCT01422629</nct_id>
  </id_info>
  <brief_title>High Intensity Focused Ultrasound (HIFU) to Treat Breast Fibroadenoma</brief_title>
  <official_title>High Intensity Focused Ultrasound (HIFU) to Treat Breast Fibroadenoma: a Feasibility Study. A Multicentric, Open, Uncontrolled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Theraclion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Theraclion</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a multicentre, open, uncontrolled trial for the observation of histological&#xD;
      changes in breast fibroadenoma following high intensity focused ultrasound (HIFU).&#xD;
&#xD;
      This study will be conducted in France in 20 patients with breast fibroadenoma with&#xD;
      indication for a surgical resection. The patient will receive an HIFU treatment and 6 months&#xD;
      after treatment, the need of the surgery is evaluated.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HIFU induced tissue necrosis assessed by histology of excised gland or reduction volume of fibroadenoma</measure>
    <time_frame>6 months after HIFU treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Volume reduction of the fibroadenoma</measure>
    <time_frame>12 months after HIFU treatment</time_frame>
    <description>reduction in volume at 2, 4, 6 and 12 months after HIFU session or total regression of the fibroadenoma evaluated with ultrasound just before surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Pain score during the HIFU treatment evaluated by the Visual Analog Scale.</measure>
    <time_frame>at treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with Adverse events</measure>
    <time_frame>at 12 months follow-up</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Breast Fibroadenoma</condition>
  <arm_group>
    <arm_group_label>High Intensity Focused Ultrasound (HIFU)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasonic ablation device</intervention_name>
    <description>High Intensity focused ultrasound treatment</description>
    <arm_group_label>High Intensity Focused Ultrasound (HIFU)</arm_group_label>
    <other_name>TH-One</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of breast fibroadenoma based on:Clinical examination, Ultrasound image and&#xD;
             mammogram for women older than 35 years, and histology&#xD;
&#xD;
          -  Fibroadenoma size superior at 1 cm at its largest dimension (measured by Ultrasound)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient pregnant or lactating&#xD;
&#xD;
          -  Microcalcifications within the lesion at the mammogram.&#xD;
&#xD;
          -  History of breast cancer or history of laser or radiation therapy to the target breast&#xD;
&#xD;
          -  Breast implant in the target breast.&#xD;
&#xD;
          -  Fibroadenoma not clearly visible on the ultrasound images (in B mode)&#xD;
&#xD;
          -  Patient participating in other trials using drugs or devices&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Loïc BOULANGER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Jeanne de Flandre, CHU de Lille - FRANCE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Jeanne de Flandre, CHU de Lille 2 Avenue Oscar Lambret</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Américain de Paris</name>
      <address>
        <city>Neuilly Sur Seine</city>
        <zip>92200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <study_first_submitted>August 18, 2011</study_first_submitted>
  <study_first_submitted_qc>August 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2011</study_first_posted>
  <last_update_submitted>April 8, 2014</last_update_submitted>
  <last_update_submitted_qc>April 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breast Fibroadenoma</keyword>
  <keyword>High Intensity Focused Ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibroadenoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

